Amicus gets positive EU regulator view for Fabry disease drug

(Reuters) - The European Medicines Agency recommended approving American biotech drug developer Amicus Therapeutics Inc's experimental Fabry disease treatment.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro